Related references
Note: Only part of the references are listed.GenBank
Dennis A. Benson et al.
NUCLEIC ACIDS RESEARCH (2011)
Flavonoids as Nutraceuticals: A Review
AR Tapas et al.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH (2011)
Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
Cheng-Chung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
Valerie Grum-Tokars et al.
VIRUS RESEARCH (2008)
Binding interaction of quereetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro:: Structure-activity relationship studies reveal salient pharmacophore features
Lili Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Inhibition of α-glucosidase and α-amylase by flavonoids
K Tadera et al.
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY (2006)
Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer
T Xu et al.
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2005)
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
CN Chen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2005)
Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate
CJ Kuo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells
L Yi et al.
JOURNAL OF VIROLOGY (2004)
Characterization of a novel coronavirus associated with severe acute respiratory syndrome
PA Rota et al.
SCIENCE (2003)
Share Paper
